Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGM - Nasdaq Real Time Price USD

Tango Therapeutics, Inc. (TNGX)

Compare
1.2800
-0.0900
(-6.57%)
At close: April 1 at 4:00:00 PM EDT
1.2800
0.00
(0.00%)
After hours: April 1 at 6:21:47 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
42,069
42,069
36,527
24,860
37,042
Operating Expense
187,664
187,664
150,700
135,931
95,232
Operating Income
-145,595
-145,595
-114,173
-111,071
-58,190
Net Non Operating Interest Income Expense
7,890
7,890
6,619
1,456
495
Other Income Expense
7,611
7,611
5,944
1,493
-248
Pretax Income
-130,094
-130,094
-101,610
-108,122
-57,943
Tax Provision
208
208
134
54
292
Net Income Common Stockholders
-130,302
-130,302
-101,744
-108,176
-58,235
Diluted NI Available to Com Stockholders
-130,302
-130,302
-101,744
-108,176
-58,235
Basic EPS
-1.19
--
-1.08
-1.23
-0.94
Diluted EPS
-1.19
--
-1.08
-1.23
-0.94
Basic Average Shares
109,226.7310
--
94,572.4480
87,820.0370
62,108.0320
Diluted Average Shares
109,226.7310
--
94,572.4480
87,820.0370
62,108.0320
Total Operating Income as Reported
-145,595
-145,595
-114,173
-111,071
-58,190
Total Expenses
187,664
187,664
150,700
135,931
95,232
Net Income from Continuing & Discontinued Operation
-130,302
-130,302
-101,744
-108,176
-58,235
Normalized Income
-130,302
-130,302
-101,744
-108,176
-58,235
Interest Income
7,890
7,890
6,619
1,456
495
Net Interest Income
7,890
7,890
6,619
1,456
495
EBIT
-145,595
-145,595
-114,173
-111,071
-58,190
EBITDA
-143,096
-143,096
-111,758
-109,463
-57,293
Reconciled Depreciation
2,499
2,499
2,415
1,608
897
Net Income from Continuing Operation Net Minority Interest
-130,302
-130,302
-101,744
-108,176
-58,235
Normalized EBITDA
-143,096
-143,096
-111,758
-109,463
-57,293
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 9/3/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ERAS Erasca, Inc.
1.2050
-12.04%
 
RLAY Relay Therapeutics, Inc.
2.4700
-5.73%
 
INZY Inozyme Pharma, Inc.
0.8700
-4.40%
 
TCRX TScan Therapeutics, Inc.
1.2700
-7.97%
 
IDYA IDEAYA Biosciences, Inc.
14.77
-9.83%
 
BCYC Bicycle Therapeutics plc
7.85
-7.54%
 
KYMR Kymera Therapeutics, Inc.
25.24
-7.80%
 
MGNX MacroGenics, Inc.
1.2200
-3.94%
 
TYRA Tyra Biosciences, Inc.
8.72
-6.24%
 
ORIC ORIC Pharmaceuticals, Inc.
5.53
-0.90%